Vol. 43 No. 1 (1996)

Articles

• The NTP phosphate donor in kinase reactions: is ATP a monopolist?

  D Shugar

  9-23

  • PDF
• Some recent trends and progress in nucleoside synthesis.

  H Vorbrüggen

  25-36

  • PDF
• Recent progress in oligonucleotide synthesis.

  W Pfleiderer, S Matysiak, F Bergmann, R Schnell

  37-44

  • PDF
• Synthesis and application of novel nucleoside phosphonates and phosphoramidites modified at the base moiety.

  F Seela, Y Chen, A Melenewski, H Rosemeyer, C Wei

  45-52

  • PDF
• Synthetic and biological applications of tricyclic analogues of guanosine.

  B Golankiewicz

  53-64

  • PDF
• Crystal structures of some acyclonucleosides with antiviral activity and related compounds.

  K B Birnbaum

  65-76

  • PDF
• "Small is beautiful": major modifications in DNA structure or dynamics by small substituents or ligands.

  W Guschlbauer

  77-94

  • PDF
• Methoxyamine attack on cytosine produces ambivalent base pairing properties of the modified base.

  Z Gdaniec, L C Sowers, G V Fazakerley

  95-105

  • PDF
• Mutagenesis and ultraviolet inactivation of transforming DNA of Haemophilus influenzae complexed with a Bacillus subtilis protein that alters DNA conformation.

  J K Setlow, B C Setlow, P Setlow

  107-114

  • PDF
• Nucleotide probes of DNA polymerases.

  G E Wright

  115-124

  • PDF
• Modified substrates of DNA polymerases and design of antivirals.

  A A Krayevsky, L A Alexandrova, N B Dyatkina, M K Kukhanova, E A Shirokova

  125-132

  • PDF
• Molecular mechanism of thymidylate synthase-catalyzed reaction and interaction of the enzyme with 2- and/or 4-substituted analogues of dUMP and 5-fluoro-dUMP.

  W Rode, A Leś

  133-142

  • PDF
• Structure-activity relationships for phosphorylation of nucleoside analogs to monophosphates by nucleoside kinases.

  N G Johansson, S Eriksson

  143-160

  • PDF
• Effects of exon sequences on splicing of model pre-mRNA substrates in vitro.

  Z Dominski, R Kole

  161-173

  • PDF
• Transfer of antivirals to skin Langerhans cells--a novel approach to anti-HIV treatment by "antiviral peplotion".

  Y Becker

  175-181

  • PDF
• NAD-analogues as potential anticancer agents: conformational restrictions as basis for selectivity.

  K W Pankiewicz, A Zatorski, K A Watanabe

  183-193

  • PDF
• New insights regarding the potential of the pronucleotide approach in antiviral chemotherapy.

  G Gosselin, J L Girardet, C Périgaud, S Benzaria, I Lefebvre, N Schlienger, A Pompon, J L Imbach

  195-208

  • PDF
• Tyrosine and its catabolites: from disease to cancer.

  R M Tanguay, R Jorquera, J Poudrier, M St-Louis

  209-216

  • PDF
• Synthesis, physicochemical and biological properties of poly-alpha-amino acids--the simplest of protein models.

  E Katchalski-Katzir

  217-226

  • PDF
• Human lipoprotein lipase deficiency: does chronic dyslipidemia lead to increased oxidative stress and mitochondrial DNA damage in blood cells?

  M R Ven Murthy, P Julien, P Singh, E Levy

  227-240

  • PDF
• Psoralen photosensitization: damages to nucleic acid and membrane lipid components.

  S Caffieri, Z Zarebska, F Dall'Acqua

  241-246

  • PDF
• Miscoding properties of isoguanine (2-oxoadenine) studied in an AMV reverse transcriptase in vitro system.

  A M Bukowska, J T Kuśmierek

  247-254

  • PDF
• Expression of small synthetic genes coding for hEGF, human epidermal growth factor, and CPTI II, serine proteinase inhibitor from Cucurbitacea, cloned in a novel expression/secretion vector in Saccharomyces cerevisiae.

  J Topczewska, B Rempoła, M Fikus

  255-264

  • PDF
• Effect of reversed orientation and length of An.Tn DNA bending sequences in the -35 and spacer domains of a consensus-like Escherichia coli promoter on its strength in vivo and gross structure of the open complex in vitro.

  T Loziński, K L Wierzchowski

  265-279

  • PDF